Developing a Machine Learning Model to Predict Pleural Adhesion Preoperatively Using Pleural Ultrasound
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · May 15, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a special type of ultrasound, called pleural ultrasound, can help doctors identify pleural adhesions in patients who are preparing for a surgery known as video-assisted thoracoscopic surgery (VATS). Pleural adhesions are areas where the layers around the lungs stick together, which can complicate surgery. The researchers are using advanced technology, called a 3D convolutional neural network, to analyze images from the ultrasound. Their goal is to see how accurately this method can detect pleural adhesions before surgery, which could make the process safer and more efficient for patients.
To be eligible for this study, patients need to be planning to undergo VATS surgery. However, those who cannot provide complete medical information or who have skin issues in the area being examined will not be able to participate. Participants in this trial can expect to undergo pleural ultrasound as part of the study, which will help researchers understand if this technology can improve surgical outcomes. The study is not yet recruiting participants, but it aims to support better patient care in thoracic surgery in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients who plan to accept VATS surgery.
- Exclusion Criteria:
- • 1. Patients who can not obtain detailed clinical information;
- • 2. Patients or their family members who can not understand the conditions and objectives of the study or refuse to participate in the study;
- • 3. Patients with conditions affecting observation, such as skin lesions, infections, or scars in the area of the chest wall to be examined.
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Shanqing Li, PhD, and MD
Study Director
Peking Union Medical College Hospital
Qingli Zhu, PhD, and MD
Principal Investigator
Peking Union Medical College Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported